The clinical spectrum of nuclear DNA-related mitochondrial disorders

Mitochondrial Disorders Caused by Nuclear Genes

Volumn 9781461437222, Issue , 2013, Pages 3-25

  Dimauro, Salvatore ^a,b   Emmanuele, Valentina ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

CoQ10 deficiency; Defect of the mitochondrial lipid milieu; Defects of intergenomic communication; Defects of mtDNA translation; Direct hits; Indirect hits; Mendelian genetics; Mitochondrial genetics; Mitochondrial Mendelian genetic overlap

Indexed keywords

EID: 84949176068     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3722-2_1     Document Type: Chapter

References (164)

1. Holt IJ, Harding AE, Morgan Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717-719
2. Wallace DC, Singh G, Lott MT et al (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-1430
3. DiMauro S, Andreu AL (2000) Mutations in mtDNA: are we scraping the bottom of the barrel? Brain Pathol 10:431-441
4. Zeviani M, Servidei S, Gellera C et al (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309-311
5. Moraes CT, Shanske S, Tritschler HJ et al (1991) mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.Am J Hum Genet 48:492- 501
6. Bourgeron T, Rustin P, Chretien D et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144-149
7. Distelmaier F, Koopman WJH, van den Heuvel LP et al (2009) Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132:833-842
8. Valsecchi F, Koopman WJH, Manjeri GR et al (2010) Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level. Devel Disabil Res Rev 16:175-182
9. Haut S, Brivet M, Touati G et al (2003)A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycemia and lactic acidosis. Hum Genet 113:118-122
10. MassaV, Fernandez-Vizarra E, Alshahwan S et al (2008) Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 82:1281-1289
11. DiMauro S (2011) A history of mitochondrial diseases. J Inher Metab Dis 34:261-276
12. DiMauro S, Davidzon G (2005) Mitochondrial DNA and disease. Ann Med 37:222-232
13. Holt IJ, Harding AE, Petty RK, Morgan Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428-433
14. TatuchY, Christodoulou J, FeigenbaumA et al (1992) Heteroplasmic mtDNA mutation (T>G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.Am J Hum Genet 50:852-858
15. Larsson NG, Holme E, Kristiansson B et al (1990) Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 28:131-136
16. McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39-42
17. Suomalainen A, Isohanni P (2010) Mitochondrial DNA depletion syndromes-many genes, common mechanisms. Neuromuscul Disord 20:429-437
18. Carrozzo R, Hirano M, Fromenty B et al (1998) Multiple mitochondrial DNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology 50:99-106
19. Rotig A, Poulton J (2009) Genetic causes of mitochondrialDNAdepletion in humans. Biochim Biophys Acta 1792:1103-1108
20. Hirano M, Lagier-Tourenne C, ValentinoMLet al (2005) Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 354:152-156
21. Tyynismaa H, Sun R, Ahola-Erkkila S et al (2012) Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet 21:66-75
22. Hakonen AH, Isohanni P, Paetau A et al (2007) Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130:3032-3040
23. Sarzi E, Goffart S, Serre V et al (2007) Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579-587
24. Wong L-JC, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150-E172
25. Chan SSL, Copeland WC (2009) DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochim Biophys Acta 1787:312-319
26. Horvath R, Hudson G, Ferrari G et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674-1684
27. DiMauro S, Davidzon G, HiranoM(2006)A polymorphic polymerase. Brain 126:1637-1639
28. Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 55:706-712
29. Davidzon G, Mancuso M, Ferraris S et al (2005) POLG mutations and Alpers syndrome. Ann Neurol 57:921-923
30. Van Goethem G, Dermaut B, Lofgren A et al (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211- 212
31. Davidzon G, Greene P, Mancuso M et al (2006) Early-onset familial; parkinsonism due to POLG mutations. Ann Neurol 59:859-862
32. Eerola J, Luoma PT, Peuralinna T et al (2010) POLG1 polyglutamine tract variants associated with Parkinson's disease. Neurosci Lett 477:1-5
33. Van Goethem G, Martin JJ, DermautBet al (2003) RecessivePOLGmutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13:133-142
34. Hakonen AH, Heiskanen S, Juvonen V et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77:430-441
35. Milone M, Brunetti-Pierri N, Tang L-Y et al (2008) Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 18:626-632
36. Smeitink J, Sengers R, Trijbels F, van den Heuvel L (2001) Human NADH: ubiquinone oxidoreductase. J Bioenerg Biomembr 33:259-266
37. Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JAM (2006) Mitochondrial complex I: structure, function and pathology. J Inher Metab Dis 29:499-515
38. Bugiani M, Invernizzi F, Alberio S et al (2004) Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 1659:136-147
39. DiMauro S, Garone C (2011) Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain. Semin Fetal Neonatal Med 16:181-189
40. Lebre AS, Rio M, Faivre d'Arcier L et al (2011)A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 48:16-23
41. Fernandez-Moreira D, Ugalde C, Smeets R et al (2007) X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73-83
42. Rustin P, RotigA(2002) Inborn errors of complex II-unusual human mitochondrial diseases. Biochim Biophys Acta 1553:117-122
43. Parfait B, Chretien D, RotigA et al (2000) Compound heterozygous mutation in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum Genet 106:236-243
44. Horvath R, Abicht A, Holinski-Feder E et al (2006) Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77:74-76
45. Van Coster R, Seneca S, Smet J et al (2003) Homozygous Gly555Glu mutation in the nuclearencoded 7-kDa flavoprotein gene causes instability of respiratory chain complex II.AmJ Med Genet 120:13-18
46. Bugiani M, Lamantea E, Invernizzi F et al (2006) Effects of riboflavin in children with complex II deficiency. Brain Dev 28:576-581
47. Birch-Machin MA, Taylor RW, Cochran B et al (2000) Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol 48:330-335
48. Quinzii CM, HiranoM(2010) Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 16:183-188
49. Trevisson E, DiMauro S, Navas P, Salviati L (2011) Coenzyme Q deficiency in muscle. Curr Opin Neurol 24:449-456
50. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A 86:2379-2382
51. Sobreira C, Hirano M, Shanske S et al (1997) Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48:1238-1243
52. Boitier E, Degoul F, Desguerre I et al (1998) A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 156:41-46
53. Di Giovanni S, Mirabella M, SpinazzolaA et al (2001) Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57:515-518
54. Auré K, Benoist JF, Ogier de Baulny H et al (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727-729
55. Musumeci O, Naini A, Slonim AE et al (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849-855
56. Lamperti C, Naini A, Hirano M et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206-1208
57. Gironi M, Lamperti C, Nemni R et al (2004) Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62:818-820
58. Artuch R, Brea-Calvo G, Briones P et al (2006) Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci 246:153-158
59. Lagier-Tourenne C, Tazir M, Lopez LC et al (2008) ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661-672
60. Mollet J, Delahodde A, Serre V et al (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623-630
61. Rotig A, Appelkvist EL, Geromel V et al (2000) Quinone-responsive multiple respiratorychain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391-395
62. Montini G, Malaventura C, Salviati L (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358:2849-2850
63. Mollet J, Giurgea I, Schlemmer D et al (2007) Prenyldiphosphate synthase (PDSS1) and OH-benzoate prenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765-772
64. Lopez LC, Schuelke M, Quinzii C et al (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.Am J Hum Genet 79:1125-1129
65. Diomedi-Camassei F, Di Giandomenico S, Santorelli F et al (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773-2780
66. Heeringa SF, Chernin G, Chaki M et al (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013-2024
67. Gempel K, Topaloglu H, Talim B et al (2007). The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130:2037-2044
68. LiangW-C, Ohkuma A, HayashiYK et al (2009) ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Neuromuscul Disord 19:212-216
69. Ohkuma A, Noguchi S, Sugie H et al (2009) Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve 39:333-342
70. Barel O, Shorer Z, Flusser H et al (2008) Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. Am J Hum Genet 82:1211-1216
71. Mayr JA, Havlickova V, Zimmermann F et al (2010) Mitochondrial ATP synthase deficiency due to a mutation in theATP5E gene for the F1 epsilon subunit. HumMol Genet 19:3430-3439
72. CizkovaA, StraneckyV, Mayr JAet al (2008)TMEM70 mutations cause isolatedATP synthase deficiency and neonatal mitochondrial encephalomyopathy. Nat Genet 40:1288-1290
73. Lazarou M, Thorburn DR, Ryan MT, McKenzie M (2009) Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta 1793:78-88
74. Hoefs SJ, Dieteren CEJ, Distelmaier F et al (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306-1315
75. Saada A, Vogel RO, Hoefs SJ et al (2009) Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 84:718-727
76. Hoefs SJG, Skjeldal OH, Rodenburg RJ et al (2010) Novel mutations in the NDUFS1 gene cause low residual activities in human complex I deficiencies. Mol Genet Metab 100:251-256
77. Fassone E, Taanman J-W, Hargreaves IP et al (2011) Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantilehypertrophic cardiomyopathy. J Med Genet 48:691-697
78. Ferreira M, Torraco A, Rizza T et al (2011) Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 12:9-17
79. Berger I, Hershkovitz E, ShaagA et al (2008) Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation. Ann Neurol 63:405-408
80. Ogilvie I, Kennaway NG, Shoubridge EA (2005) A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 115:2784-2792
81. Sugiana C, Pagliarini DJ, McKenzie M et al (2008) Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 83:468-478
82. Saada A, Edvardson S, Rapoport M et al (2008) C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 82:32-38
83. Dunning CJ, McKenzie M, Sugiana C et al (2007) Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 26:3227-3237
84. Gerards M, van den Bosch BJC, Danhauser K et al (2011) Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 134:210-219
85. Haack TB, Danhauser K, Haberberger B et al (2010) Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 42:1131-1134
86. Saada A, Edvardson S, Shaag A et al (2012) Combined OXPHOS complex I and IV defect, due to mutated complex I assembly factor C20ORF7. J Inherit Metab Dis 35:125-131
87. Calvo SE, Tucker EJ, ComptonA et al (2010) High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet 42:851-858
88. Pagliarini DJ, Calvo SE, ChangBet al (2008)Amitochondrial protein compendium elucidates complex I disease biology. Cell 134:112-123
89. Ghezzi D, Goffrini P, Uziel G et al. (2009) SDHAF1, encoding a LYR complex II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 41:654-656
90. Fernandez-Vizarra E, Bugiani M, Goffrini P et al (2007) Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalomyopathy. Hum Mol Genet 16:1241-1252
91. Visapaa I, Fellman V, Vesa J et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863-876
92. de Lonlay P, Valnot I, Barrientos A et al (2001) A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29:57-60
93. Blazquez A, Gil-Borlado MC, Moran M et al (2009) Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient. Neuromuscul Disord 19:143-146
94. Hinson JT, Fantin VR, Schonberger J et al (2007) Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N Engl J Med 356:809-819
95. Ghezzi D, Arzuffi P, Zordan M et al (2011) Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in human and flies. Nat Genet 43:259-263
96. DiMauro S, Servidei S, Zeviani M et al (1987) Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 22:498-506
97. Van Coster R, Lombes A, DeVivo DC et al (1991) Cytochrome c oxidase-associated Leigh syndrome: phenotypic features and pathogenetic speculations. J Neurol Sci 104:97-111
98. Zhu Z, Yao J, Johns T et al (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20:337-343
99. Tiranti V, Hoertnagel K, Carrozzo R et al (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609-1621
100. Tiranti V, Jaksch M, Hofmann S et al (1999) Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol 46:161-166
101. Moslemi AR, Tulinius M, Darin N et al (2003) SURF1 gene mutations in three cases with Leigh syndrome and cytochrome c oxidase deficiency. Neurology 61:991-993
102. Coenen MJH, Smeitink JAM, Pots JM et al (2006) Sequence analysis of the structural nuclear encoded subunits and assembly genes of cytochrome c oxidase in a cohort of 10 isolated complex IV-deficient patients revealed five mutations. J Child Neurol 21:508-511
103. Bohm M, Pronicka E, Karczmarewicz E et al (2006) Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency. Pediatr Res 59:21-26
104. Darin N, Moslemi AR, Lebon S et al (2003) Genotypes and clinical phenotypes in children with cytochrome c oxidase deficiency. Neuropediatrics 34:311-317
105. Sue CM, Karadimas C, Checcarelli N et al (2000) Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol 47:589-595
106. Pequignot MO, Dey R, Zeviani M et al (2001) Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase deficiency. Hum Mutat 17:374-381
107. Rossi A, Biancheri R, Bruno C et al (2003) Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. Am J Neuradiol 24:1188-1191
108. Rahman S, Brown RM, ChongWKet al (2001) ASURF1 gene mutation presenting as isolated leukodystrophy. Ann Neurol 49:797-800
109. Salviati L, Freehauf C, Sacconi S et al (2004) Novel SURF1 mutation in a child with subacute encephalopathy and without the radiological features of Leigh syndrome. Am J Med Genet 128A:195-198
110. Tay SKH, Sacconi S, Akman HO et al (2005) Unusual clinical presentation in four cases of Leigh disease, cytochrome c oxidase deficiency, and SURF1 gene mutations. J Child Neurol 20:670-674
111. Papadopoulou LC, Sue CM, Davidson MM et al (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333-337
112. Jaksch M, Ogilvie I, Yao J et al (2000) Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet 9:795-801
113. Vesela K, Hulkova H, Hansikova H et al (2008) Structural analysis of tissues affected by cytochrome c oxidase deficiency due to mutations in the SCO2 gene. APMIS 116:41-49
114. Knuf M, Faber J, Huth RG et al (2007) Identification of a novel compound heterozygote SCO2 mutation cytochrome c oxidase deficient fatal infantile cardioencephalomyopathy. Acta Paediatr 96:128-134
115. Tay SKH, Shanske S, Kaplan P, DiMauro S (2004) Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality. Arch Neurol 61:950-952
116. Leary SC, Mattman A, Wai T et al (2006) A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy. Mol Genet Metab 89:129-133
117. Jaksch M, Horvath R, Horn N et al (2001) Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Neurology 57:1440-1446
118. Jaksch M, Paret C, Stucka R et al (2001) Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet 10:3025-3035
119. Salviati L, Hernandez-Rosa E, Walker WF et al (2002) Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem J 363:321-327
120. Freisinger P, Horvath R, Macmillan C et al (2004) Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper? J Inherit Metab Dis 27:67-79
121. Tarnopolsky MA, Bourgeois JM, Fu MH et al (2004) Novel SCO2 mutation (G1521A) presenting as a spinal muscular atrophy type I phenotype.Am J Med GenetA 125A:310-314
122. Salviati L, Sacconi S, Rasalan MM et al (2002) Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimicsWerdnig-Hoffmann disease. Arch Neurol 59:862-865
123. Pronicki M, Kowalski P, Piekutowska-Abramczuk D et al (2010)A homozygous mutation in the SCO2 gene causes a spinal muscular atrophy like presentation with stridor and respiratory insufficiency. Eur J Paediatr Neurol 14:253-260
124. Oskoui M, Davidzon G, Pascual J et al (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122-1126
125. Valnot I, Osmond S, Gigarel N et al (2000) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.Am J Hum Genet 67:1104-1109
126. Brosel S, Yang H, Tanji K et al (2010) Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues. Am J Pathol 177:2541-2548
127. Horvath R, Lochmuller H, Stucka R et al (2000) Characterization of human SCO1 and COX17 genes in mitochondrial cytochrome-c-oxidase deficiency. Biochem Biophys Res Commun 276:530-533
128. Sacconi S, Salviati L, Sue CM et al (2003) Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res 53:224-230
129. Valnot I, von Kleist-Retzow JC, Barrientos A et al (2000) A mutation in the human heme-A: farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245-1249
130. Antonicka H, Leary SC, Guercin GH et al (2003) Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and acount for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693-2702
131. Kennaway NG, Carrero-Valenzuela RD, Ewart G et al (1990) Isoforms of mammalian cytochrome c oxidase: correlation with human cytochrome c oxidase deficiency. Pediatr Res 28:529-535
132. Antonicka H, Mattman A, Carlson CG et al (2003) Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101-114
133. Oquendo CE, Antonicka H, Shoubridge EA et al (2004) Functional and genetic studies demonstrate that mutation in the COX15 gene can cause Leigh syndrome. J Med Genet 41:540-544
134. Bugiani M, Tiranti V, Farina L et al (2005) Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency. J Med Genet 42:e28
135. Huigsloot M, Nijtmans LGJ, Szklarczyk R et al (2011)Amutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy.AmJHumGenet 88:488- 493
136. Ghezzi D, Saada A, D'Adamo P et al (2008) FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am J Hum Genet 83:415-423
137. MoothaVK, Lepage P, MillerKet al (2003) Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Nat Acad Sci U S A 100:605-610
138. Morin C, Mitchell G, Larochelle J et al (1993) Clinical, metabolic, and genetic aspects of cytochrome c oxidase deficiency in Saguenay-Lac-Saint-Jean.Am J Hum Genet 53:488-496
139. Xu F, Morin C, Mitchell G et al (2004) The tole of LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA. Biochem J 382:331-336
140. Weraarpachai W, Antonicka H, Sasarman F et al (2009) Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome. Nat Genet 41:833-837
141. Seeger J, Schrank B, Pyle A et al (2010) Clinical and neuropathological findings in patients with TACO1 mutations. Neuromuscul Disord 20:720-724
142. Tiranti V, D'Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239-252
143. TirantiV, Viscomi C, HildebrandtT et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200-205
144. Mineri R, Rimoldi M, Burlina AB et al (2008) Identification ofnew mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet 45:473-478
145. De Meirleir L, Seneca S, LissensWet al (2004) Respiratory chain complexV deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120-124
146. Honzik T, Tesarova M, Mayr JA et al (2010) Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation. Arch Dis Child 95:296-301
147. Cameron JM, Levandovskiy V, MacKay N et al (2011) Complex V TMEM70 deficiency results in mitochondrial nucleoid disorganization. Mitochondrion 11:191-199
148. Shchelochkov OA, Li FY, Wang J et al (2010) Milder clinical course of type IV 3- methylglutaconic aciduria due to a novel mutation in TMEM70. Mol Genet Metab 101:282-285
149. Spiegel R, Khayat M, Shalev SA et al (2011) TMEM70 mutations are a common cause of nuclear encodedATP synthase assembly defect: further delineation of a new syndrome. J Med Genet 48:177-182
150. Chrzanowska-Lightowlers ZMA, Horvath R, Lightowlers RN (2011) 175th ENMC International workshop: mitochondrial protein synthesis in health and disease, 25-27th June 2010, Naarden, The Netherlands. Neuromusc Dis 21:142-147
151. Tucker EJ, Hershman SG, Kohrer C et al (2011) Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 14:428-434
152. Scheper GC, van der Klok T, van Andel RJ et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534-539
153. Synofzik M, Schicks J, Lindig T et al (2011) Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation. J Med Genet 48:713- 715
154. Smits P, Antonicka H, van Hasselt PM et al (2011) Mutation in subdomain G1 is associated with combinedOXPHOSdeficiency in fibroblasts but not in muscle. Eur JHumGenet 19:275- 279
155. Smits P, Saada A, Wortmann SB et al (2011) Mutation in mitopchondrial ribosomal protein MRPS22 leads to Cornelia de Lange phenotype, brain abnormalities and hypertrophic cardiomyopathy. Eur J Hum Genet 19:394-399
156. Zeharia A, Shaag A, Pappo O et al (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401-407
157. Schara U, von Kleist-Retzow J-C, Lainka E et al (2011) Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis 34:197-201
158. Uusimaa J, Jungbluth H, FratterCet al (2011) Reversible infantile respiratory chain deficiency is a unique, genetically heterogeneous mitochondrial disease. J Med Genet 48:660-668
159. Claypool SM, Koehler CM(2012) The complexity of cardiolipin in health and disease. Trends Biochem Sci 37:32-41
160. Schlame M, Ren M (2006) Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450-5455
161. Mitsuhashi S, Ohkuma A, Talim B et al (2011) A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. Am J Hum Genet 88:845-851
162. Gutierrez-Rios P, Kalra AA, Wilson JD et al (2012) Congenital megaconial myopathy due to a novel defect in the choline kinase beta (CHKB) gene. Arch Neurol 69(5):657-661
163. Mitsuhashi S, Hatakeyama H, Karahashi M et al (2011) Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy. Hum Mol Genet 20:3841-3851
164. DiMauro S, Hirano M, Schon EA (2006) Approaches to the treatment of mitochondrial diseases. Muscle Nerve 34:265-283